Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-11-15
1996-06-18
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 77, A61K 3158
Patent
active
055278078
ABSTRACT:
Described are new 7.beta.-substituted 4-aza-5.alpha.-cholestan-3-ones and related compounds as 5.alpha.-reductase inhibitors.
REFERENCES:
patent: 2227876 (1941-01-01), Bolt
patent: 3239417 (1966-03-01), DiTullio et al.
patent: 3264301 (1966-08-01), Doorenboos
patent: 3285918 (1966-11-01), Doorenboos et al.
patent: 4220775 (1980-09-01), Rasmusson et al.
patent: 4317817 (1982-03-01), Blohm et al.
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 4596812 (1986-06-01), Chidsey, III et al.
patent: 4732897 (1988-03-01), Cainelli et al.
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4845104 (1989-07-01), Carlin et al.
patent: 4859681 (1989-08-01), Rasmusson et al.
patent: 4882319 (1989-11-01), Holt et al.
patent: 4888336 (1989-12-01), Holt et al.
patent: 4910226 (1990-03-01), Holt et al.
patent: 5049562 (1991-09-01), Rasmusson et al.
patent: 5120742 (1992-06-01), Rasmusson et al.
patent: 5175155 (1992-12-01), Juniewicz et al.
patent: 5237064 (1993-08-01), Bakshi et al.
patent: 5359071 (1994-10-01), Durette et al.
Geldof et al., Abstract: Eur. J. Cancer, vol. 26, "Enzyme Inhibitors in Hormone Dependent Prostate Cancer Treatment", p. 188 (1990).
Kedderis et al., Toxicology and Applied Pharmacology, vol. 93, (1988), "Studies with Nitrogen-Containing Steroids and Freshly Isolated Rat Hepatocytes: Role of Cytochrome P-450 in Detoxication", pp. 403-412.
Kedderis et al., Toxicology and Applied Pharmacology, vol. 103, (1990), "The Role of Metabolism and Covalent Binding in the Cytotoxicity of a Nitrogen-Containing Steroid toward Rat Hepatocytes", pp. 222-227.
Endo., vol. 91, No. 2, pp. 427-437 (1972) by Neri, et al., "A Biological Profile of a Non-steroida Antiandrogen, SOH 13521 . . . ".
Steroids, 14, 269-283(1969), by Nayfeh, et al., "Metabolism of Progesterone by Rat Testicular Homogenates".
Endo., vol. 92, pp. 1216-1222 (1973) by Voight & Hsia.
J. Pharm. Sci., 62, No. 4, pp. 638-640 (1973) by Doorenbos & Solomons, "Synthesis & Antimicrobial Properties of 17 Beta-Isopentyloxy-4-Aza-5-Alpha-Androstane and the 4-Methyl Derivative".
J. Pharm. Sci., 60, No. 8, pp. 1234-1235 (1971) by Doorenbos & Brown, "417 Alpha-Dimethyl-4-Aza-5 Alpha-Androstane-17 beta-ol Acetate & Related Azasteroids".
J. Pharm., 63, No. 4, pp. 620-622 (1974) by Doorenbos & Kim, "Synthesis & Evaluation of Antimicrobial Properties of Amidinoazaandrostanes and Guanidinoazaandrostanes".
J. Med. Chem. (1986) 29 (11): pp. 2298-3115 by Rasmusson, et al., "Aza Steroids, Structure-Activity Relationships".
Prostate (1986) 9(1): pp. 65-75 by Brooks, et al., "Prostatic Effects Induced in Dogs By . . . 5 alpha-Reductase Inhibitors".
Steroids (1986) 47 (1): pp. 1-19 by Brooks, et al., "5 Alpha-Reductase Inhibitory . . . Activities of Some 4-Aza-Steroids in the rat".
Endocr. (1985) 117 (2): pp. 571-579, by Liang, et al., "Species Differences in Prostatic Steroidal 5 Alpha-Reductases of Rat, Dog and Human".
J. Med. Chem. (1984) 27 (12) : pp. 1690-1701, by Rasmusson, et al., "Azasteroids as Inhibitors of Rat Prostatic 5 alpha-reductase".
J. Org. Chem. (1981) vol. 46, No. 7, pp. 1442-1446, T. Back, et al., "N-Chloroazasteroids . . . ".
Chem. Abstracts, vol. 95, 109055, by T. Liang, et al. "Inhibition of 5 Alpha-Receptor Binding . . . by a 4-Methyl-4-aza-Steroid"(1981).
JNCI, vol. 74, No. 2, pp. 475-481 (Feb. 1985), by N. Kadohama, et al., "Retardation of Prostate Tumor Progression in the Noble Rat by 4-Methyl-4-Aza-Steroidal Inhibitors of 5 Alpha-Reductase".
The Prostate, vol. 10, pp. 189-197 (1987) by G. Andriole, et al., "The Effect of 4MA . . . on the Growth of . . . Human Tumors . . . ".
J. Endocr., vol. 57, pp. 111-121 (1973) by K. D. Bingham, et al., "The Metabolism of Testosterone by Human Male Scalp Skin".
Bioinorganic Chemistry, 17, pp. 372-376 (1986) by B. W. Metcalf, et al., "Patent Inhibition of Human Steroid . . . by 3-Androstene-3-Carboxylic Acid".
Biochemistry, 1990, vol. 29, pp. 2815-2824, by M. A. Levy, et al., "Inhibition of Rat Liver Steroid 5 Alpha-Reductase".
J. Med. Chem., 1990, vol. 33, pp. 943-950, by D. A. Holt, et al. "Steroidal A Ring Carboyxlic Acids . . . ".
J. Steroid Biochem., vol. 34, Nos. 1-6, pp. 571-575 (1989), by M. A. Levy, et al., "Interaction Between Rat Prostatic 5 Alpha-Reductase . . . ".
J. Med. Chem., vol. 33, pp. 937-942 (1990) by D. A. Holt, et al., "Steroidal A Ring Aryl Carboxylic Acids".
TIPS, Dec. 1989, vol. 10, pp. 491-495, by D. W. Metcalf, et al., "Inhibitors of . . . 5 Alpha-Reductase in Benign Prostatic Hyperplasia . . . ".
Steroids, vol. 35, No. 3 (Mar. 1980) pp. 1-7, by L. Murphy, et al., "Effect of Estradiol on a . . . Binding Protein in the Uterus of the Mouse".
Prostate, vol. 9, pp. 311-318 (1986) by N. Stone, et al., "Estrogen Formation in Human Prostatic Tissue . . . ".
Steroids, vol. 47, No. 1, pp. 1-19 (1986) by J. R. Brooks, et al., "5 Alpha-Reductase Inhibitory . . . Activities of Some 4-Azasteroids . . . ".
Lancet, No. 1986, No. 8515, pp. 1095-1096, by F. Labrie, et al. "Combination therapy in prostate cancer".
J. Clin. Endocrin. and Metabl., vol. 55, No. 1, pp. 188-193 (1987), by R. Rittmaster, et al., "The Effects of . . . a 5 Alpha-Reductase Inhibitor . . . ".
J. Clin. Endocrin and Metab., vol. 74, No. 2, pp. 345-350 (1990), by A. Diani, et al., "Hair Growth Effects of Oral Administration of Finasteride . . . ".
J. Clin. Endocrinol. Metab. 67, No. 4, pp. 808-816 (1988), by N. Bruchovsky, et al., "Kinetic Parameters of 5 Alpha-Reductase Activity in Stroma & Epithelium of Normal Hyperplastic & Carcinomatous Human Prostates".
J. Steroid Biochem. 26 (3) pp. 349-353 (1987), by R. Hudson, "Comparison of Nuclear 5 Alpha-Reductase Activities in the Stromal and Epithelial Fractions of Human Prostatic Tissue".
J. Biol. Chem. 251 (19) pp. 5895-5900 (1976), by R. J. Moore, et al., "Steroid 5 Alpha-Reductase in Cultured Human Fibroblasts".
J. Biol. Chem. 264 (27) pp. 16249-16255 (1989), by S. Andersson, et al., "Expression Cloning & Regulation of steroid 5 alpha-Reductase and Exzyme Essential for Male Sexual Differentiation".
Proc. Nat'l Acad Science 87, pp. 3640-3644 (1990), by S. Andersson, et al., "Structural & Biochemical Properties of cloned and expressed human and rat steroid 5 alpha-reductases".
Nature 354, pp. 159-161 (Nov. 14, 1991), by S. Andersson, et al., "Deletion of Steroid 5 Alpha-Reductase-2 Gene in Male Pseudohermaphroditism".
Biol of Reproduction vol. 45, pp. 168-173 (1992), by J. D. Wilson, "Syndromes of Androgen Resistance".
J. Cancer Res. Clin. Oncol. 118, pp. 50-55 (1992), by A. Geldof, et al., "Consideration of the Use of . . . 4MA . . . in Prostate Cancer Therapy".
The Prostate 18, pp. 215-227 (1991), by J. Brooks, et al., "Effect of Castration, DES, Flutamide, and MK-906 on Growth of the Dunning Rat Prostatic Carcinoma . . . ".
Eur. J. Pharm. 183 (5), p. 1757 (1990), by Y. Masubuchi, et al., "Lack of DHT Inhibition . . . by Treatment of 4MA . . . ".
Stinson, Chem. Eng. News, Jun. 29, 1992, pp. 7-8.
Helliker, Wall Street Jour., Jun. 7, 1991, pp. A1 and A7 (1991).
Diani, et al, Jour. of Clin & Metab., vol. 74, pp. 345-350, (1992).
Back, et al, Jour. Org. Chem., vol. 54, pp. 1904-1910 (1992).
Back, et al, Can. Jour. of Chem., vol. 69, No. 9, pp. 1482-1486 (1991).
Suddoth et al., Pharmacotherapy, vol. 13, No. 4, pp. 309-329 (1993), "Finasteride: The First 5-alpha Reductase Inhibitor".
Rhodes et al., "Effects of 1 Year Treatment with Oral MK386, an Inhibitor of Type 1 5Alpha-Reductase, in the Stumptailed Macaque (Macaca arctoides)", presented at Society for Investigative Dermatology Meeting, Chicago, Illinois, May 24-28, 1995.
Bakshi Raman K.
Harris Georgianna
Patel Gool F.
Rasmusson Gary H.
Tolman Richard L.
Daus Donald G.
Fitch Catherine D.
Giesser Joanne M.
Merck & Co. , Inc.
LandOfFree
7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7.beta.-substituted-4-aza-5.alpha.-cholestan-3-ones as 5.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-223137